← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 1999First marketed drug
Dec 10, 1990First NDA
Sep 28, 2000Last known activity
Aug 31, 2018
Timeline
1950s
- Jan 1, 1952
Population Council— Founded
1990s
- Dec 10, 1990
norgestrel— NDA Secondary Org
2010s
- Aug 10, 2018
segesterone— NDA Organization
Drugs by trial phase (12 distinct, 23 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (3)
Recent trials (38)
- NCT03452111CollaboratorPhase 2Aug 31, 2018
- NCT03432416CollaboratorPhase 2Feb 12, 2018
- NCT03230539Study directorPhase 1May 1, 2017
- NCT03230539Lead sponsorPhase 1May 1, 2017
- NCT02875119Lead sponsorPhase 1Jan 1, 2017
- NCT02994602CollaboratorPhase 1Jan 1, 2017
- NCT02875119Study chairPhase 1Jan 1, 2017
- NCT02451826Lead sponsorPhase 1/Phase 2May 1, 2015
- NCT02451826Study directorPhase 1/Phase 2May 1, 2015
- NCT02236026Study directorPhase 1Sep 1, 2014
- NCT02236026Lead sponsorPhase 1Sep 1, 2014
- NCT02033109Study chairPhase 1May 1, 2014
- NCT02033109Study directorPhase 1May 1, 2014
- NCT02033109Lead sponsorPhase 1May 1, 2014
- NCT02215395Lead sponsorPhase 1Mar 1, 2014
Details
- Founded
- New York, NY, US Jan 1, 1952
- First NDA
- Sep 28, 2000
- Last known activity
- Aug 31, 2018
Designations held
- Priority review